Similar to other subunits of the RFC family, RFC5 is expressed in a variety of cancers, such as head and neck squamous cell carcinoma [48], prostate cancer [49], cervical cancer [50], and diffuse large B-cell lymphoma (DLBCL) [51] than the normal. Here, RFC5 is linked to prostate cancer.